JBM (Healthcare) Limited (HKG:2161)

JBM (Healthcare) Revenue

In the fiscal year ending March 31, 2026, JBM (Healthcare) had annual revenue of 834.63M HKD with 6.69% growth. JBM (Healthcare) had revenue of 404.99M in the half year ending March 31, 2026, with 25.93% growth. That makes JBM (Healthcare) the 22,201st largest company in the world by revenue and 1,301st in Hong Kong.

• Revenue: 834.63M
• Revenue Growth: +6.69%
• P/S Ratio: 1.63
• Revenue / Employee: 2.07M
• Employees: 404
• Market Cap: 1.36B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Proprietary Chinese Medicines 468.40M 56.1%
• Branded Medicines 279.97M 33.5%
• Health and Wellness Products 86.26M 10.3%

By Geography

Chart

• Hong Kong 697.52M 83.6%
• Mainland China 67.84M 8.1%
• Singapore 24.03M 2.9%
• Others 23.28M 2.8%
• Macau 21.96M 2.6%

Fiscal year ended Mar 31, 2026 See the full JBM (Healthcare) breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	834.63M	52.34M	6.69%
Mar 31, 2025	782.29M	133.88M	20.65%
Mar 31, 2024	648.42M	128.09M	24.62%
Mar 31, 2023	520.32M	114.18M	28.11%
Mar 31, 2022	406.14M	8.98M	2.26%

Data Source: S&P Global Market Intelligence Last updated: Jul 15, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Oct 27, 2026

Data Sources Report a data error